TRIP13 and B-cell non-Hodgkin lymphoma: Interestingly, TRIP13 (thyroid hormone receptor interactor 13) characterized by DepMap as Strongly selective was critical for the maintenance of several cancer cell lines including B–cell lymphoma OCILY19 and human eosinophilic leukemia EOL1.